Xiaohong Han

4.1k total citations
183 papers, 2.7k citations indexed

About

Xiaohong Han is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaohong Han has authored 183 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 61 papers in Pulmonary and Respiratory Medicine and 48 papers in Molecular Biology. Recurrent topics in Xiaohong Han's work include Lung Cancer Treatments and Mutations (41 papers), Lymphoma Diagnosis and Treatment (31 papers) and Lung Cancer Research Studies (26 papers). Xiaohong Han is often cited by papers focused on Lung Cancer Treatments and Mutations (41 papers), Lymphoma Diagnosis and Treatment (31 papers) and Lung Cancer Research Studies (26 papers). Xiaohong Han collaborates with scholars based in China, United States and India. Xiaohong Han's co-authors include Yuankai Shi, Jiarui Yao, Qing Yi, Lei Zhang, Yinchen Shen, Shuai Wang, Yuankai Shi, Sheng Yang, Larry W. Kwak and Jianfei Wang and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaohong Han

173 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohong Han China 27 1.1k 899 674 449 447 183 2.7k
Maria Tzardi Greece 32 1.2k 1.1× 677 0.8× 497 0.7× 530 1.2× 507 1.1× 143 3.1k
Kevin H. Eng United States 24 754 0.7× 1.1k 1.3× 625 0.9× 651 1.4× 94 0.2× 98 2.9k
Andries M. Bergman Netherlands 33 1.8k 1.7× 1.6k 1.8× 1.6k 2.4× 211 0.5× 240 0.5× 158 4.5k
Helen H.W. Chen Taiwan 27 1.1k 1.0× 953 1.1× 537 0.8× 324 0.7× 243 0.5× 60 2.8k
Mukta M. Webber United States 31 645 0.6× 1.3k 1.5× 721 1.1× 183 0.4× 152 0.3× 76 3.1k
Kazuhiro Nomoto Japan 25 527 0.5× 768 0.9× 230 0.3× 341 0.8× 191 0.4× 91 2.2k
Cezary Cybulski Poland 34 1.5k 1.4× 1.9k 2.1× 435 0.6× 281 0.6× 986 2.2× 182 4.6k
Dan Su China 32 993 0.9× 1.4k 1.5× 571 0.8× 196 0.4× 213 0.5× 139 2.7k
Mengzhao Wang China 31 2.4k 2.3× 973 1.1× 2.5k 3.6× 247 0.6× 185 0.4× 229 3.9k
Qinghua Zhou China 29 1.5k 1.4× 1.2k 1.3× 1.7k 2.5× 387 0.9× 261 0.6× 215 3.8k

Countries citing papers authored by Xiaohong Han

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Han more than expected).

Fields of papers citing papers by Xiaohong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Han. The network helps show where Xiaohong Han may publish in the future.

Co-authorship network of co-authors of Xiaohong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Han. A scholar is included among the top collaborators of Xiaohong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Han. Xiaohong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Diyi, Zhen Wu, Jianfang Zhou, et al.. (2025). Pre-existing Anti-AAV9 antibodies in the Chinese healthy and rare disease populations: Implications for gene therapy. Virus Research. 354. 199549–199549. 1 indexed citations
2.
3.
Dai, Liyuan, Shasha Wang, Zhishang Zhang, et al.. (2024). A Novel IgG–IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules. Genomics Proteomics & Bioinformatics. 22(6).
4.
5.
Liu, Jingfu, et al.. (2023). An exploratory study of MaaS in Shandong. Advances in Economics and Management Research. 1(3). 233–233. 1 indexed citations
6.
7.
Zhang, Zhishang, Le Tang, Jiarui Yao, et al.. (2023). High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 32(5). 726–738. 1 indexed citations
8.
Wang, Shasha, Lin Li, Yajun He, et al.. (2023). Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC. Cancer Immunology Immunotherapy. 72(7). 2423–2442. 13 indexed citations
9.
10.
Yang, Yi, Hongbing Mei, Xiaohong Han, et al.. (2023). Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression. Cellular & Molecular Biology Letters. 28(1). 96–96. 7 indexed citations
11.
Xie, Tongji, et al.. (2023). An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma. iScience. 26(10). 107894–107894. 2 indexed citations
12.
Zhong, Qiaofeng, Yunxia Tao, Haizhu Chen, et al.. (2021). The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020. The Lancet Regional Health - Western Pacific. 11. 100151–100151. 19 indexed citations
13.
Wu, Gang, Keping Qiu, Jarken Esimbek, et al.. (2018). Extended ammonia observations towards the integral-shaped filament. Springer Link (Chiba Institute of Technology). 12 indexed citations
14.
15.
Han, Xiaohong, et al.. (2015). Application of urinary bladder temperature monitoring among patients with different cardiac operations. Zhonghua xiandai huli zazhi. 21(11). 1264–1266. 1 indexed citations
16.
Wang, Shuai, Xiaohong Han, Jianfei Wang, Jiarui Yao, & Yuankai Shi. (2014). Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts. PLoS ONE. 9(3). e89848–e89848. 29 indexed citations
17.
18.
Han, Xiaohong, et al.. (2011). Sequence analysis reveals mosaic genome of Aichi virus. Virology Journal. 8(1). 390–390. 14 indexed citations
19.
Sun, Tong, Yifeng Zhou, Ming Yang, et al.. (2008). Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer. Cancer Research. 68(17). 7025–7034. 138 indexed citations
20.
Sun, Tong, Yifeng Zhou, Hua Li, et al.. (2005). FASL –844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. The Journal of Experimental Medicine. 202(7). 967–974. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Tzardi Breakdown of academic impact, for papers by Kevin H. Eng Breakdown of academic impact, for papers by Andries M. Bergman Breakdown of academic impact, for papers by Helen H.W. Chen Breakdown of academic impact, for papers by Mukta M. Webber Breakdown of academic impact, for papers by Kazuhiro Nomoto Breakdown of academic impact, for papers by Cezary Cybulski Breakdown of academic impact, for papers by Dan Su Breakdown of academic impact, for papers by Mengzhao Wang Breakdown of academic impact, for papers by Qinghua Zhou
Rankless by CCL
2026